Log In
Monday 21st May 2018

RFID given cautious backing

30th June 2006

US authorities are set to monitor the use of RFID tags to prevent the spread of counterfeit drugs. The Food and Drug Administration has given cautious backing to the use of RFID tags within the drug supply chain but says it will wait until the technology further matures before issuing any kind of mandate.

In a recent report the FDA criticised the overall lack of progress in the area of electronic track and trace across the US drug supply chain but described RFID technology as ‘promising’, urging stakeholders to move quickly to implement the technology.


Share this page


There are no comments for this article, be the first to comment!

Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

Mayden - Innovative cloud-based web development for the healthcare sector
© Mayden Foundation 2018